These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 72430)

  • 21. HLA, DRW (IA-like) and additional surface antigens expressed on adenoid T and B lymphocytes.
    Gazit E; Mizrahi Y; Orgad S; Efter T; Lewenstein M; Ostfeld E
    Vox Sang; 1979; 37(4):193-200. PubMed ID: 386611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of beta2-microglobulin and HLA on the surface of human cells. I. T and B lymphocytes and lymphoblasts.
    Dorval G; Welsh KI; Nilsson K; Wigzell H
    Scand J Immunol; 1977; 6(4):255-63. PubMed ID: 67632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can anti HLA-A and -B antibodies inhibit the MLC test?
    Jonker M; van Rood JJ
    Tissue Antigens; 1978 Mar; 11(3):251-64. PubMed ID: 77568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alloantigens of the human T (HT) genetic region of the HLA linkage group.
    Gazit E; Terhorst C; Mahoney RJ; Yunis EJ
    Hum Immunol; 1980 Sep; 1(2):97-109. PubMed ID: 6167547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level.
    Lipinski M; Fridman WH; Tursz T; Vincent C; Pious D; Fellous M
    J Exp Med; 1979 Dec; 150(6):1310-22. PubMed ID: 229186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA antigens: rabbit antisera reacting with all A series or all B series specificities.
    Cresswell P; Ayres JL
    Eur J Immunol; 1976 Feb; 6(2):82-8. PubMed ID: 786698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening and use of high titered anti-HLA-DR sera in PHA-blast complement fixation and B-lymphocytotoxicity techniques.
    Lepage V; Gaudy Y; Terrier E; Dausset J; Colombani J
    Tissue Antigens; 1981 Jan; 17(1):37-42. PubMed ID: 6166083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of immune phagocytosis by human sera with HLA A, B, C and DR but not with DQ or EM type reactivity.
    Neppert J; Pohl E; Mueller-Eckhardt C
    Vox Sang; 1986; 51(2):122-6. PubMed ID: 2430362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of different technical approaches for the research of human anti-Ia alloantisera.
    Borelli I; Amoroso A; Richiardi P; Curtoni ES
    Tissue Antigens; 1982 May; 19(5):380-7. PubMed ID: 7051418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New HLA class I-like alloantigens expressed on blast cells.
    Crepaldi T; Peruccio D; Lecchi M; Resegotti L; Grazia Guerra M; Funaro A; Richiardi P
    J Immunogenet; 1987; 14(4-5):219-29. PubMed ID: 3331642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological inhibition of blast transformation to purified streptococcal antigens by planned immunization in HLA (A,B) compatible unrelated individuals.
    Greenberg LJ; Chopky RL; Noreen H; Gray ED; Yunis EJ; Ferrara GB
    Vox Sang; 1978; 34(3):136-42. PubMed ID: 414452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of alloantibodies reacting with PHA-activated T lymphocytes, unexplainable by known HLA activities.
    Kim SJ; Christiansen FT; Gosar I; Silver DM; Pollack MS; Dupont B
    Hum Immunol; 1980 Dec; 1(4):347-55. PubMed ID: 6973560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of isoimmune antibodies against a population of human B-lymphocytes].
    Zotikov EA; Tananov AT; Udovichenko AI; Katandzhan NM
    Biull Eksp Biol Med; 1978 Sep; 86(9):324-6. PubMed ID: 308820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal transplantation: HLA-linked, non-cytotoxic antibodies develop after blood transfusion.
    MacLeod AM; Stewart KN; Urbaniak S; Catto GR
    Clin Sci (Lond); 1988 Apr; 74(4):385-8. PubMed ID: 3281787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal alloantibody responses during early pregnancy detected by a cellular enzyme-linked immunospecific assay.
    Cunningham C; Power DA; Innes A; Lind T; Catto GR
    Hum Immunol; 1987 May; 19(1):7-16. PubMed ID: 3495525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin.
    Arce-Gomez B; Jones EA; Barnstable CJ; Solomon E; Bodmer WF
    Tissue Antigens; 1978 Feb; 11(2):96-112. PubMed ID: 77067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non HLA antigenic determinants expressed on activated T and B human lymphocytes.
    Wollman EE; Guilherme L; Lepage V; Dausset J
    Tissue Antigens; 1984 Jan; 23(1):1-11. PubMed ID: 6199865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple method for screening human T and B lymphocyte alloantibodies.
    Hsia S; Ward FE; Amos DB
    J Immunol Methods; 1976; 12(3-4):337-43. PubMed ID: 1085785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.